CALHM2 and neoplasm: We have recently conducted a study in which an in vivo CRISPR screen and orthogonal single-cell profiling of infiltrating NK cells across different tumor models have convergently identified the novel NK suppressor Calcium homeostasis modulator family member 2 (CALHM2).